
| Serial Number | 98069328 |
| Word Mark | KUDO BIOTECHNOLOGY |
| Filing Date | Monday, July 3, 2023 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, September 29, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 31, 2024 |
| Goods and Services | Custom manufacturing of pharmaceuticals, biological preparations and drug conjugates; custom assembly of pharmaceuticals, biological preparations and drug conjugates; custom manufacturing of pharmaceuticals; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates |
| Goods and Services | Pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemico-pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; drugs for medical purposes, namely, anticancer preparations; biological preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicinal preparations for human purposes for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; pharmaceutical preparations, substances and compositions for the prevention of cancer, infectious disease, metabolic disease, and central nervous system disease and conditions |
| Pseudo Mark | KUDO BIO TECHNOLOGY |
| NOT AVAILABLE | "BIOTECHNOLOGY" |
| Goods and Services | Scientific and engineering research services relating to the manufacture of biotechnology and pharmaceutical products; development of products for others; pharmaceutical drug development services; research and development of new products; biochemical research and development; custom design and development of chemical reagents, pharmaceutical formulations, and biologics; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of nucleic acid medicines; research and development of mRNA drug substance and drug products; biomedical research services; development of pharmaceutical preparations and medicines |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 3, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 3, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 3, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | KUDO BIOTECHNOLOGY, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | NEEDHAM, MA 02494 |
| Party Name | KUDO BIOTECHNOLOGY, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | NEEDHAM, MA 02494 |
| Party Name | RVAC Medicines Pte. Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Waltham, MA 02451 |
| Event Date | Event Description |
| Friday, March 22, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, March 22, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, March 22, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 24, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, July 6, 2023 | NEW APPLICATION ENTERED |
| Thursday, August 3, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 24, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Friday, March 15, 2024 | ASSIGNED TO EXAMINER |
| Monday, June 24, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Monday, September 23, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 23, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, September 24, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 22, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, October 22, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, October 22, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Monday, October 7, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, October 22, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 22, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 25, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 31, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 31, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 25, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, September 29, 2025 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, September 29, 2025 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |